Predicting peritoneal recurrence in gastric cancer with serosal invasion using a pathomics nomogram

Dexin Chen1, Jianbo Lai1, Jiaxin Cheng1

  • 1Department of General Surgery, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, P.R. China.

Iscience
|March 30, 2023
PubMed
Summary

A new pathomics signature can predict peritoneal recurrence in gastric cancer (GC) with serosal invasion. This signature, combined with clinical factors, forms a nomogram to assess individual patient risk for this lethal recurrence pattern.

Related Concept Videos